Physician profile
Kyle Bohm
NPI 1477878288
$1,234.36
in general payments reported to CMS, 2019-2025
28 companies · $89.12 in 2025
The $89.12 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $54.21 · 2021: $211 · 2022: $230 · 2023: $387 · 2024: $42.96 · 2025: $89.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $208.22 | 2023 | Sx-One Microknife |
| Bioness INC | $137.46 | 2021 | |
| Amgen INC. | $120.65 | 2019-2023 | Prolia, Evenity |
| Endo Pharmaceuticals INC. | $99.16 | 2019-2023 | Xiaflex |
| Acumed LLC | $98.45 | 2019 | |
| Depuy Synthes Sales INC. | $45.94 | 2025 | Orthocord, Quickanchor Orthocord |
| Pinnacle, INC | $42.40 | 2019-2024 | |
| Stryker Corporation | $41.36 | 2020-2024 | Conextions Tr Tendon Repair System-Implant Mechanism |
| Boston Scientific Corporation | $40.92 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Janssen Biotech, INC. | $39.76 | 2022 | |
| Nevro Corp. | $34.80 | 2023 | Senza |
| Acera Surgical, INC. | $29.28 | 2023 | Restrata Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $29.15 | 2019-2022 | |
| Alvogen INC | $27.74 | 2022 | |
| Horizon Therapeutics Plc | $27.13 | 2021-2023 | Krystexxa |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $26.34 | 2022 | |
| Si-Bone, INC. | $25.38 | 2025 | |
| Lundbeck LLC | $21.16 | 2023 | Vyepti |
| Abbvie INC. | $18.03 | 2023 | Qulipta, Ubrelvy |
| Alexion Pharmaceuticals, INC. | $17.99 | 2022 | |
| Mimedx Group, INC. | $17.80 | 2025 | |
| Radius Health, INC. | $15.54 | 2022 | |
| Sanara Medtech INC. | $12.92 | 2023 | Celleraterx |
| Linvatec Corporation | $12.50 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.82 | 2022 | |
| Pfizer INC. | $11.12 | 2019 | |
| Novartis Pharmaceuticals Corporation | $10.80 | 2019 | |
| Dynasplint Systems INC. | $10.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Bohm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.